Inventor
MACLEAN JOHN K
US8 patents
Patents
8 patentsUS10221146B2Mar 5, 2019
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME6 citations83
US9809561B2Nov 7, 2017
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME8 citations83
US9745265B2Aug 29, 2017
4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME9 citations83
US9663522B2May 30, 2017
3-aminocycloalkyl compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME15 citations83
US9556168B2Jan 31, 2017
N-alkylated indole and indazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME16 citations83
US9487490B2Nov 8, 2016
3-cyclohexenyl and cyclohexyl substituted indole and indazole compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME15 citations83
US10196354B2Feb 5, 2019
4-heteroaryl substituted benzoic acid compounds as RORgammaT inhibitors and uses thereof
MERCK SHARP & DOHME2 citations72
US10745364B2Aug 18, 2020
Tetrahydronaphthyridine, benzoxazine, aza-benzoxazine and related bicyclic compounds for inhibition of RORgamma activity and the treatment of disease
MERCK SHARP & DOHME0 citations51